LAG3 and brain neoplasm: Separately, dysregulation of checkpoint markers, such as PD-L1, PD-1, LAG-3, and TIM-3, have been implicated in immune suppression, although the exact relationship of these markers to brain tumor-mediated immune suppression remains unclear.